S428-1262 Screening compound: N~6~-methyl-2-oxo-N~6~-{2-oxo-2-[3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]ethyl}-1,2,3,4-tetrahydro-6-quinolinesulfonamide

S428-1262 Screening compound: N~6~-methyl-2-oxo-N~6~-{2-oxo-2-[3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]ethyl}-1,2,3,4-tetrahydro-6-quinolinesulfonamide
S428-1262 Screening compound: N~6~-methyl-2-oxo-N~6~-{2-oxo-2-[3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]ethyl}-1,2,3,4-tetrahydro-6-quinolinesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S428-1262
N~6~-methyl-2-oxo-N~6~-{2-oxo-2-[3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]ethyl}-1,2,3,4-tetrahydro-6-quinolinesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-1262

Molecular Formula

C23H29N5O6S (C23 H29 N5 O6 S)

Compound Name

N~6~-methyl-2-oxo-N~6~-{2-oxo-2-[3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]ethyl}-1,2,3,4-tetrahydro-6-quinolinesulfonamide

IUPAC name

n/a

SMILES

CN(CC(N(CC1)CC1c1nc(C2CCOCC2)no1)=O)S(c(cc1)cc(CC2)c1NC2=O)(=O)=O

InChI

InChI=1S/C23H29N5O6S/c1-27(35(31,32)18-3-4-19-16(12-18)2-5-20(29)24-19)14-21(30)28-9-6-17(13-28)23-25-22(26-34-23)15-7-10-33-11-8-15/h3-4,12,15,17H,2,5-11,13-14H2,1H3,(H,24,29)/t17-/m1/s1

InChI Key

REFSSFBMBKCJCV-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD29011851

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.58

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

1.428

Distribution Coefficient, logD

1.426

Water Solubility, LogSw

-2.63

Polar Surface Area

113.822

Acid Dissociation Constant (pKa)

9.90

Base Dissociation Constant (pKb)

-1.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.50

S428-1262 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with S428-1262 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S428-1262?
Check Price and Availability of S428-1262, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S428-1262 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S428-1262
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S428-1262
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S428-1262 available by request